Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bento Biology Platforms is a patient-powered research and decentralized clinical trial (DCT) company focused on democratizing access to clinical research and precision medicine. The company provides a consumer-grade digital experience and self-service biosampling tools, such as the 'Bento Biology Box,' to enable contactless data collection and participation from a patient's home. By utilizing blockchain technology and incentive models like 'play-to-learn' (P2L) and 'participate-to-earn' (P2E), Bento Bio aims to solve the diversity problem in clinical trials by building trust with underrepresented communities. The platform supports biopharma sponsors in accelerating therapeutic development, population genomics, and long-term follow-up for cell and gene therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bento.